Pharmacometrics-Based Considerations for the Design of a Pharmacogenomic Clinical Trial Assessing Irinotecan Safety

por Minichmayr, Iris K., Karlsson, Mats O., Jönsson, Siv
Publicado 2021

Model-Informed Translation of In Vitro Effects of Short-, Prolonged- and Continuous-Infusion Meropenem against Pseudomonas aeruginosa to Clinical Settings

por Minichmayr, Iris K., Kappetein, Suzanne, Brill, Margreke J. E., Friberg, Lena E.
Publicado 2022

Pharmacokinetics of doripenem in plasma and epithelial lining fluid (ELF): comparison of two dosage regimens

por Oesterreicher, Zoe, Minichmayr, Iris, Sauermann, Robert, Marhofer, Daniela, Lackner, Edith, Jäger, Walter, Maier-Salamon, Alexandra, Schwameis, Richard, Kloft, Charlotte, Zeitlinger, Markus
Publicado 2017

Role of renal function in risk assessment of target non-attainment after standard dosing of meropenem in critically ill patients: a prospective observational study

por Ehmann, Lisa, Zoller, Michael, Minichmayr, Iris K., Scharf, Christina, Maier, Barbara, Schmitt, Maximilian V., Hartung, Niklas, Huisinga, Wilhelm, Vogeser, Michael, Frey, Lorenz, Zander, Johannes, Kloft, Charlotte
Publicado 2017

Towards model-informed precision dosing of piperacillin: multicenter systematic external evaluation of pharmacokinetic models in critically ill adults with a focus on Bayesian fore...

por Greppmair, Sebastian, Brinkmann, Alexander, Roehr, Anka, Frey, Otto, Hagel, Stefan, Dorn, Christoph, Marsot, Amélie, El-Haffaf, Ibrahim, Zoller, Michael, Saller, Thomas, Zander, Johannes, Schatz, Lea Marie, Scharf, Christina, Briegel, Josef, Minichmayr, Iris K., Wicha, Sebastian G., Liebchen, Uwe
Publicado 2023